Ultrasonography.  2019 Jul;38(3):191-199. 10.14366/usg.18043.

Hepatocellular carcinoma surveillance: Eastern and Western perspectives

Affiliations
  • 1Department of Radiology, University Hospitals Paris Nord Val de Seine, Clichy, France. maxime.ronot@aphp.fr
  • 2University Paris Diderot, Sorbonne Paris Cité, Paris, France.
  • 3INSERM U1149, Centre de Recherche Biomédicale Bichat-Beaujon, CRB3, Paris, France.

Abstract

Eastern and Western guidelines for the management of hepatocellular carcinoma (HCC) are known to significantly differ on many points, because they reflect different diagnostic and therapeutic approaches to this cancer. Importantly, these guidelines are primarily consensus-driven when it comes to surveillance, both in term of the tests used and surveillance program design. The main difference between East and West lies in clinical practice, as several Eastern countries implement coordinated and systematic surveillance programs, while most Western countries rely on individual adherence to surveillance recommendations. This review article presents an overview of the evidence supporting surveillance programs for HCC, with a particular focus on the efficacy, cost-effectiveness, and consequences of this approach for patient survival. Western and Eastern guideline recommendations are discussed.

Keyword

Ultrasound; Surveillance; Cirrhosis; Imaging

MeSH Terms

Carcinoma, Hepatocellular*
Fibrosis
Humans
Ultrasonography
Full Text Links
  • USG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr